Krs Capital Management, LLC Dexcom Inc Transaction History

Krs Capital Management, LLC

  • $137 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024
BUY
$110.31 - $140.45 $79,643 - $101,404
722 Added 26.94%
3,402 $385,000
Q1 2024

Apr 16, 2024
BUY
$114.22 - $140.1 $31,981 - $39,228
280 Added 11.67%
2,680 $371,000
Q4 2022

Jan 19, 2023
BUY
$84.98 - $122.67 $203,952 - $294,408
2,400 New
2,400 $0
Q2 2022

Aug 02, 2022
SELL
$67.99 - $132.89 $40,794 - $79,733
-600 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$129.87 - $162.82 $77,922 - $97,692
600 New
600 $322,000

Others Institutions Holding DXCM

# of Institutions
1,013
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email